000 | 01478 a2200409 4500 | ||
---|---|---|---|
005 | 20250513041018.0 | ||
264 | 0 | _c19950510 | |
008 | 199505s 0 0 eng d | ||
022 | _a0931-0509 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMizumoto, D | |
245 | 0 | 0 |
_aIdentification of risk factors on secondary hyperparathyroidism undergoing long-term haemodialysis with vitamin D3. _h[electronic resource] |
260 |
_bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _c1994 |
||
300 |
_a1751-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxycholecalciferols _xtherapeutic use |
650 | 0 | 4 |
_aHyperparathyroidism, Secondary _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aParathyroid Hormone _xblood |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aWatanabe, Y | |
700 | 1 | _aFukuzawa, Y | |
700 | 1 | _aYuzawa, Y | |
700 | 1 | _aYamazaki, C | |
773 | 0 |
_tNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _gvol. 9 _gno. 12 _gp. 1751-8 |
|
999 |
_c7707649 _d7707649 |